| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy
|
Halfdanarson, T.R.
|
|
|
17 |
12 |
p. 1849-1850
|
artikel
|
| 2 |
An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer
|
Mathias, C.
|
|
|
17 |
12 |
p. 1792-1796
|
artikel
|
| 3 |
A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer
|
Popat, S.
|
|
|
17 |
12 |
p. 1810-1817
|
artikel
|
| 4 |
A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma
|
Schmittel, A.
|
|
|
17 |
12 |
p. 1826-1829
|
artikel
|
| 5 |
author index
|
|
|
|
17 |
12 |
p. 1873-1885
|
artikel
|
| 6 |
Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with β-catenin levels and outcome in patients with epithelial ovarian cancer
|
Bamias, A.
|
|
|
17 |
12 |
p. 1797-1802
|
artikel
|
| 7 |
Bevacizumab is active in malignant effusion
|
Pichelmayer, O.
|
|
|
17 |
12 |
p. 1853
|
artikel
|
| 8 |
Chemotherapy with bevacizumab, irinotecan, 5-fluorouracil and leucovorin (IFL) associated with a large, embolizing thrombus in the thoracic aorta
|
Yoon, S.
|
|
|
17 |
12 |
p. 1851-1852
|
artikel
|
| 9 |
Do we bear any moral responsibility for improving cancer care in Africa?
|
Kerr, F.
|
|
|
17 |
12 |
p. 1730-1731
|
artikel
|
| 10 |
EGFR expression in colon cancer: a break in the clouds
|
Etienne-Grimaldi, M.-C.
|
|
|
17 |
12 |
p. 1850-1851
|
artikel
|
| 11 |
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
|
Ceppi, P.
|
|
|
17 |
12 |
p. 1818-1825
|
artikel
|
| 12 |
18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference
|
Hoffmann, M.
|
|
|
17 |
12 |
p. 1761-1765
|
artikel
|
| 13 |
First—select the target: better choice of adjuvant treatments for breast cancer patients
|
Goldhirsch, A.
|
|
|
17 |
12 |
p. 1772-1776
|
artikel
|
| 14 |
Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art
|
Mornex, F.
|
|
|
17 |
12 |
p. 1743-1747
|
artikel
|
| 15 |
Increased chondroitin sulphate proteoglycan expression (B5 immunoreactivity) in metastases of uveal melanoma
|
Kiewe, P.
|
|
|
17 |
12 |
p. 1830-1834
|
artikel
|
| 16 |
in this issue
|
|
|
|
17 |
12 |
p. 1725
|
artikel
|
| 17 |
Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy
|
Baz, R.
|
|
|
17 |
12 |
p. 1766-1771
|
artikel
|
| 18 |
Management of the side-effects of intravenous bisphosphonates: targeting the serum parathyroid hormone elevation
|
Berruti, A.
|
|
|
17 |
12 |
p. 1854-1855
|
artikel
|
| 19 |
Menopausal-type symptoms in young breast cancer survivors
|
Leining, M.G.
|
|
|
17 |
12 |
p. 1777-1782
|
artikel
|
| 20 |
Occupational exposure to diesel exhausts and risk for lung cancer in a population-based case–control study in Italy
|
Richiardi, L.
|
|
|
17 |
12 |
p. 1842-1847
|
artikel
|
| 21 |
Oxaliplatin in inoperable or metastatic bladder cancer
|
Mir, O.
|
|
|
17 |
12 |
p. 1853-1854
|
artikel
|
| 22 |
Pathology practice patterns affect lymph node evaluation and outcome of colon cancer: a population-based study
|
Lemmens, V.E.
|
|
|
17 |
12 |
p. 1803-1809
|
artikel
|
| 23 |
Rationale for the use of somatostatin analogs as antitumor agents
|
Susini, C.
|
|
|
17 |
12 |
p. 1733-1742
|
artikel
|
| 24 |
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials
|
Franklin, J.
|
|
|
17 |
12 |
p. 1749-1760
|
artikel
|
| 25 |
subject index
|
|
|
|
17 |
12 |
p. 1857-1871
|
artikel
|
| 26 |
Table of Contents
|
|
|
|
17 |
12 |
p. iv-v
|
artikel
|
| 27 |
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group
|
Gogas, H.
|
|
|
17 |
12 |
p. 1835-1841
|
artikel
|
| 28 |
The impact of treatment on the risk of second malignancy after Hodgkin's disease
|
Ng, A.K.
|
|
|
17 |
12 |
p. 1727-1729
|
artikel
|
| 29 |
Time trends of breast cancer mortality in Spain during the period 1977–2001 and Bayesian approach for projections during 2002–2016
|
Clèries, R.
|
|
|
17 |
12 |
p. 1783-1791
|
artikel
|
Tijdschrift beschrijving